Protandim is
a delay supplement that fights oxidative pressure through Nrf2 initial.
Oxidative pressure is unavoidable for everyone, happens when our tissues
produce risky by product known as free radicals which are highly reactive
molecules with unpaired electrons. Life vantage issued a voluntary recall of
select lots of Protandim due to potential health risks arising from the
possible inclusion of small metal fragments. Protandim consists mainly of a
blend of 5 herbal ingredients.
Ø Milk thistle
Ø Bascopa
Ø Ashwagandha
Ø Green tea
Ø Turmeric
This
combination is suggested to increase the activity of substances in the body
called Nrf2, which regulates the expression of the majority of anti-oxidant
genes in the body. Anti-oxidants have been long been promoted and researched as
weapons against cancer, cardiovascular disease, and aging in general. Protandim
reduce the oxidative pressure, produced through the procedure of residing life
is inevitable for everyone. Comprised of natural place components, Protandim is
a trademarked, science
Is Protandim safe?
The maker of
Protandim does not directly promote it for the treatment or prevention of any
disease. The proposed benefit of Protandim is the reduction of oxidative
stress. Protandim is sold multi level marketing process. These may include
claims of it being an anti –aging product, or that it recues the risk of
cancers or other chronic disease. Their prior mentioned study of 29 healthy
patients stated that no side effects were noted in any patients after 120 days
of supplementation. This is too small of a population to get information about
serious side effects that may be less common or occur after longer period of
time. Some lots of product were recalled in 2012 due to possibility of metal
fragments in the supplements. This was due to a infected turmeric extract batch
that was used to create the product. These are risky with any product prescribed
medications,but the risk is higher with health supplements.
https://www.youtube.com/watch?v=g9xDHA27wC4&feature=youtu.be |
No comments:
Post a Comment